Römer T J, Brennan J F, Fitzmaurice M, Feldstein M L, Deinum G, Myles J L, Kramer J R, Lees R S, Feld M S
Leiden University Medical Center, The Netherlands.
Circulation. 1998 Mar 10;97(9):878-85. doi: 10.1161/01.cir.97.9.878.
Lesion composition, rather than size or volume, determines whether an atherosclerotic plaque will progress, regress, or rupture, but current techniques cannot provide precise quantitative information about lesion composition. We have developed a technique to assess the pathological state of human coronary artery samples by quantifying their chemical composition with near-infrared Raman spectroscopy.
Coronary artery samples (n=165) obtained from explanted recipient hearts were illuminated with 830-nm infrared light. Raman spectra were collected from the tissue and processed to quantify the relative weights of cholesterol, cholesterol esters, triglycerides and phospholipids, and calcium salts in the examined artery location. The artery locations were then classified by a pathologist and grouped as either nonatherosclerotic tissue, noncalcified plaque, or calcified plaque. Nonatherosclerotic tissue, which included normal artery and intimal fibroplasia, contained an average of approximately 4+/-3% cholesterol, whereas noncalcified plaques had approximately 26+/-10% and calcified plaques approximately 19+/-10% cholesterol in the noncalcified regions. The average relative weight of calcium salts was 1+/-2% in noncalcified plaques and 41+/-21% in calcified plaques. To make this quantitative chemical information clinically useful, we developed a diagnostic algorithm, based on a first set of 97 samples, that demonstrated a strong correlation of the relative weights of cholesterol and calcium salts with histological diagnoses of the same locations. This algorithm was then prospectively tested on a second set of 68 samples. The algorithm correctly classified 64 of these new samples, thus demonstrating the accuracy and robustness of the method.
The pathological state of a given human coronary artery may be assessed by quantifying its chemical composition, which can be done rapidly with Raman spectroscopic techniques. When Raman spectra are obtained clinically via optical fibers, Raman spectroscopy may be useful in monitoring the progression and regression of atherosclerosis, predicting plaque rupture, and selecting proper therapeutic intervention.
病变的组成而非大小或体积决定了动脉粥样硬化斑块是会进展、消退还是破裂,但目前的技术无法提供有关病变组成的精确量化信息。我们开发了一种技术,通过近红外拉曼光谱对人体冠状动脉样本的化学成分进行量化,从而评估其病理状态。
从移植受者心脏获取的冠状动脉样本(n = 165)用830纳米红外光照射。收集组织的拉曼光谱并进行处理,以量化所检查动脉部位胆固醇、胆固醇酯、甘油三酯、磷脂和钙盐的相对含量。然后由病理学家对动脉部位进行分类,并分为非动脉粥样硬化组织、非钙化斑块或钙化斑块。非动脉粥样硬化组织包括正常动脉和内膜纤维增生,其中胆固醇平均含量约为4±3%,而非钙化斑块中胆固醇含量约为26±10%,钙化斑块非钙化区域胆固醇含量约为19±10%。非钙化斑块中钙盐的平均相对含量为1±2%,钙化斑块中为41±21%。为使这些定量化学信息具有临床实用性,我们基于97个样本的第一组数据开发了一种诊断算法,该算法显示胆固醇和钙盐的相对含量与相同部位的组织学诊断具有很强的相关性。然后对第二组68个样本进行前瞻性测试。该算法正确分类了其中64个新样本,从而证明了该方法的准确性和稳健性。
通过量化给定人体冠状动脉的化学成分可评估其病理状态,这可以通过拉曼光谱技术快速完成。当通过光纤在临床上获取拉曼光谱时,拉曼光谱可能有助于监测动脉粥样硬化的进展和消退、预测斑块破裂以及选择合适的治疗干预措施。